GLP-1 & Weight Cycling: Risks of Yo-Yo Dieting & Health Impacts
The Risks of Pausing and Restarting Weight Loss Medications
The rising popularity of GLP-1 receptor agonists like Ozempic and Wegovy has led to questions about whether it’s safe – and effective – to stop and restart these medications. Whereas the idea of “cycling” these drugs might seem appealing, emerging evidence suggests that pausing and resuming treatment can undermine weight loss efforts and potentially carry broader health risks. The core concern isn’t necessarily the medication itself, but the metabolic and psychological consequences of repeated weight fluctuations.
These medications, initially developed to treat type 2 diabetes, operate by mimicking a natural hormone that regulates appetite and blood sugar. They’ve proven highly effective for weight management, but maintaining that weight loss long-term requires a sustained approach. Stopping and starting treatment can disrupt this process, leading to what’s known as weight cycling – a pattern of losing and regaining weight.
Weight Cycling and Cardiometabolic Health
Weight cycling, also sometimes referred to as “yo-yo dieting,” isn’t a benign process. A large observational study of over 83,000 adults treated at Vanderbilt University Medical Center between 1997 and 2020 revealed a significant link between weight fluctuations and increased risk for several serious health conditions. The study, which followed patients for years, found that those who experienced weight yo-yoing had a substantially higher risk of heart failure, obstructive sleep apnea, metabolic dysfunction-associated steatotic liver disease (MASLD), and type 2 diabetes. These associations remained significant even after researchers accounted for factors like initial body mass index, age, sex, smoking status, race, and other medications.
It’s essential to note that this was an observational study, meaning it can’t definitively prove that weight cycling causes these conditions. However, it does highlight a concerning correlation and points to potential mechanisms at play. Each cycle of weight loss and regain appears to shift body composition, leading to a decrease in muscle mass and an increase in fat. When weight is regained, the body tends to store it as fat rather than rebuilding muscle, which slows metabolism and makes future weight gain easier. Weight cycling also triggers inflammation, a known contributor to chronic diseases like heart failure, MASLD, and type 2 diabetes.
The Impact on Metabolism and Muscle Mass
Dr. Meghan Garcia-Webb, a board-certified internal, lifestyle, and obesity medicine physician in Wellesley, Massachusetts, explains that even temporary pauses in GLP-1 medication can be problematic. “If the intervals between shots are long enough, this can cause some weight regain, which can be very frustrating for patients,” she says. Dr. Garcia-Webb emphasizes that repeated cycles of loss and regain can have both metabolic and psychological consequences.
The loss of muscle mass during weight loss is a key concern. Muscle tissue is metabolically active, meaning it burns calories even at rest. Losing muscle slows down your metabolism, making it harder to lose weight and easier to regain it. This metabolic slowdown can create a vicious cycle, where each subsequent weight loss attempt becomes more challenging.
What Does This Mean for Patients on GLP-1s?
The findings underscore the importance of viewing GLP-1 medications as part of a long-term, comprehensive weight management plan, rather than a quick fix. Simply stopping and restarting the medication without addressing underlying lifestyle factors – such as diet and exercise – is unlikely to yield sustainable results and may even be detrimental to health.
Sara Velayati, MD, an obesity medicine specialist and assistant professor at Albert Einstein College of Medicine in New York City, adds that “in general, repeated cycles of weight loss and regain is associated with worsened cardiometabolic risk factors.” This suggests that maintaining a stable weight, even if it’s not at the initial target, may be preferable to repeated fluctuations.
Beyond the Physical: The Psychological Impact
The psychological toll of weight cycling should not be underestimated. Repeatedly losing and regaining weight can lead to feelings of frustration, discouragement, and even shame. These negative emotions can contribute to disordered eating patterns and make it even more difficult to maintain a healthy lifestyle. A supportive healthcare team, including a physician, registered dietitian, and potentially a therapist, can help patients navigate these challenges.
What’s Next: Ongoing Research and Personalized Approaches
While the Vanderbilt study provides valuable insights, further research is needed to fully understand the long-term effects of weight cycling and to identify strategies for mitigating its risks. Researchers are exploring the optimal duration of GLP-1 therapy, as well as the role of lifestyle interventions in maintaining weight loss after discontinuing medication.
Currently, the focus is shifting towards personalized weight management plans that take into account individual metabolic profiles, lifestyle factors, and psychological well-being. A one-size-fits-all approach is unlikely to be effective, and patients should work closely with their healthcare providers to develop a plan that is tailored to their specific needs. Dr. Garcia-Webb, for example, offers a hybrid model of care combining weight medicine with life coaching, recognizing the importance of addressing both the physical and psychological aspects of weight management.
For individuals currently on GLP-1 medications, the key takeaway is to discuss any plans to pause or discontinue treatment with their healthcare provider. A careful assessment of the potential risks and benefits is essential, and a plan should be in place to minimize the likelihood of weight regain and to address any underlying lifestyle factors that may contribute to weight cycling.